Virtus Biotech ETF
BBPNYSEARCAVirtus Investment PartnersEquity
As of Oct 16, 2026 close
- Assets (AUM)
- $128.74M
- Expense ratio
- 0.34%
- Dividend yield
- -
- Holdings
- 68
- 52-week range
- $71.65$110.05
- Volume (live)
- -
- Avg. volume (3M)
- 14.10K
BBP ETF: Virtus Biotech ETF - Price, Holdings & Analysis
Virtus Biotech ETF Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fund characteristics, expense ratio, dividend yield, and performance metrics
| Day's Range | $100.04 - $105.35 |
|---|---|
| 52-Week High | $110.05 |
| 52-Week Low | $71.65 |
| Open | $105.35 |
| Volume (last close) | 30.58K |
| Average Volume (3M) | 14.10K |
| 1 Day Change | +2.71% |
|---|---|
| 1 Month Change | −0.35% |
| 6 Month Change | +18.96% |
| YTD Change | +31.22% |
| 1 Year Change | +45.11% |
| 5 Year Change | +106.79% |
| 10 Year Change | +244.73% |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
| Last Dividend Ex-Date | Dec 20, 2017 |
| Assets (AUM) | $128.74M |
|---|---|
| Expense Ratio | 0.34% |
| Total Holdings | 68 |
| Inception Date | Dec 16, 2014 |
| 50-Day MA | $104.31 |
|---|---|
| 200-Day MA | $91.08 |
| RSI | 45.60 |
| Stochastic %K | 30.63 |
| Stochastic %D | 32.06 |
Source: Exchange price data and fund disclosures. Data as of Oct 16, 2026. Data sources and methodology
BBP at a Glance
Virtus Biotech ETF (BBP) is an equity ETF from Virtus Investment Partners, launched in December 2014. It manages $128.74M in assets and charges a 0.34% expense ratio, about $34 a year per $10,000 invested.
As of its Oct 4, 2026 holdings, it holds 68 positions. The largest are Moderna, Inc (MRNA, 5.14%), Iovance Biotherapeutics, Inc. (IOVA, 4.58%) and Omeros Corporation (OMER, 2.96%). The top 10 holdings make up 27.4% of the fund. By sector it leans toward Healthcare (100.0%). 94.0% of assets are in the United States.
It does not currently pay distributions. As of the Oct 16, 2026 close, the share price is up 45.1% over one year, up 106.8% over five years and up 244.7% over ten years (price change, excluding distributions).
Frequently Asked Questions About Virtus Biotech ETF
What is the current price of BBP?
The latest BBP price is $100.15 (Oct 16, 2026 close). The 52-week range is $71.65–$110.05. The share price is up 45.1% over the past year (price change, excluding distributions).
What is the expense ratio for BBP?
BBP's annual expense ratio is 0.34%. This represents the yearly cost of holding the fund, deducted from total returns. Compare with similar Equity ETFs in the ETF Screener.
Does BBP pay dividends?
Virtus Biotech ETF does not currently pay dividends. Check the ETF Screener for dividend-focused alternatives in the Equity category.
What are the top holdings of BBP?
As of Oct 4, 2026, BBP's largest holdings are Moderna, Inc (5.1%), Iovance Biotherapeutics, Inc. (4.6%), Omeros Corporation (3.0%) (combined weight: 12.7%). The fund holds 68 total positions. View the complete portfolio breakdown in the Holdings section.
How does BBP compare to similar ETFs?
Compare BBP (0.34% expense ratio, $129M AUM) against similar Equity ETFs using the ETF Screener. Filter by expense ratio, dividend yield, and performance to find alternatives.